High linear energy transfer (LET) radiations are important to human health since some 40,000 workers in the US are at risk each year for exposures to low-energy neutrons. Also, there is considerable public concern over possible exposures to alpha particles emitted by radon gases. Estimations of the relative biological effectiveness (RBE) of such high-LET radiations are typically made by calculating the ratios of doses in Gy that yield the same level of biological effect as X- or gamma-rays. However, at the level of the cell target, the harmful effects of ionizing radiation do not depend on radiation """"""""dose"""""""" in the classical sense, but more precisely, on the spatial and temporal distributions of ionizations within critical target sites at the nanometer level. Thus, to understand the mechanisms by which radiations of differing LET cause damage to biologically important molecules, effects must be studied at the single cell level for radiations having well defined LET. To characterize the effects of high-LET radiations in inducing relevant genomic damage in human somatic cells, we will evaluate chromosome aberrations in lymphocytes exposed to track segment radiations of narrowly defined LET. We will use a novel approach to irradiate single-cell layers with high-LET accelerated particles produced by the van de Graaff accelerator at RARAF. Chromosome damage will be quantified using classical methods, and by state-of- the-art techniques using fluorescence in situ hybridization with chromosome-specific """"""""painting probes"""""""". In addition to studying the spectrum of aberrations induced as a function of radiation dose in cGy, we will characterize the effects of radiation of each LET on the basis of damage induced on a per track per cell basis. For selected LETs, we will also conduct studies to determine the extent to which dimethyl sulfoxide and WR-1065 protect against damage induced by radiations of differing LET. Our objectives are to produce a detailed profile of radiation- induced damage at the single-cell level in a human cell type in relation to the spatial and temporal distributions of ionizing clusters deposited within critical DNA targets, and to derive precise estimates of the relative biological effectiveness of high- LET radiations at the level of the cell.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA051388-05
Application #
2094243
Study Section
Radiation Study Section (RAD)
Project Start
1990-08-06
Project End
1997-08-31
Budget Start
1994-09-30
Budget End
1995-08-31
Support Year
5
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Oak Ridge Associated Universities
Department
Type
DUNS #
City
Oak Ridge
State
TN
Country
United States
Zip Code
37831
McFee, A F; Sayer, A M; Salomaa, S I et al. (1997) Methods for improving the yield and quality of metaphase preparations for FISH probing of human lymphocyte chromosomes. Environ Mol Mutagen 29:98-104
Hoffmann, G R; Littlefield, L G (1995) Enhancement of the activity of bleomycin by cysteamine in a micronucleus assay in G0 human lymphocytes. Toxicol Lett 78:147-51
Hoffmann, G R; Sayer, A M; Littlefield, L G (1994) Potentiation of bleomycin by the aminothiol WR-1065 in assays for chromosomal damage in G0 human lymphocytes. Mutat Res 307:273-83
Hoffmann, G R; Colyer, S P; Littlefield, L G (1993) Induction of micronuclei by bleomycin in G0 human lymphocytes: II. Potentiation by radioprotectors. Environ Mol Mutagen 21:136-43
Hoffmann, G R; Colyer, S P; Littlefield, L G (1993) Induction of micronuclei by bleomycin in G0 human lymphocytes: I. Dose-response and distribution. Environ Mol Mutagen 21:130-5
Littlefield, L G; Joiner, E E; Colyer, S P et al. (1993) Concentration-dependent protection against X-ray-induced chromosome aberrations in human lymphocytes by the aminothiol WR-1065. Radiat Res 133:88-93
Littlefield, L G; Hoffmann, G R (1993) Modulation of the clastogenic activity of ionizing radiation and bleomycin by the aminothiol WR-1065. Environ Mol Mutagen 22:225-30